Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,537 | -9,775 | -27,140 | -20,105 | -12,206 |
| Depreciation Amortization | 3,313 | 2,211 | 4,250 | 3,102 | 2,069 |
| Accounts receivable | 136 | -619 | 264 | -1,076 | -1,800 |
| Accounts payable and accrued liabilities | 77 | 828 | -1,118 | 262 | -230 |
| Other Working Capital | -1,209 | 2,605 | -2,010 | -2,055 | -2,001 |
| Other Operating Activity | 1,310 | 763 | 874 | 831 | 2,041 |
| Operating Cash Flow | $-14,910 | $-3,987 | $-24,880 | $-19,041 | $-12,127 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,755 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,035 | -832 | -6,760 | -3,821 | -1,923 |
| Investing Cash Flow | $-21,790 | $-832 | $-6,760 | $-3,821 | $-1,923 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 63,750 | 30,000 | 19,688 |
| Debt Repayment | 0 | N/A | -11,250 | N/A | N/A |
| Common Stock Issued | 38,017 | 38,017 | 2 | 1 | 1 |
| Common Stock Repurchased | N/A | N/A | -2 | -2 | N/A |
| Other Financing Activity | 0 | 0 | -1,800 | -363 | -363 |
| Financing Cash Flow | $38,017 | $38,017 | $50,700 | $29,636 | $19,326 |
| Beginning Cash Position | 26,133 | 26,133 | 7,070 | 7,077 | 7,077 |
| End Cash Position | 27,450 | 59,331 | 26,130 | 13,851 | 12,353 |
| Net Cash Flow | $1,317 | $33,198 | $19,050 | $6,774 | $5,276 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,910 | -3,987 | -24,880 | -19,041 | -12,127 |
| Capital Expenditure | -2,035 | -832 | -6,770 | -3,821 | -1,923 |
| Free Cash Flow | -16,945 | -4,819 | -31,650 | -22,862 | -14,050 |